Literature DB >> 19187009

Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay.

Karen M Kleman-Leyer1, Tony A Klink, Andrew L Kopp, Thane A Westermeyer, Mark D Koeff, Brad R Larson, Tracy J Worzella, Cori A Pinchard, Sebastianus A T van de Kar, Guido J R Zaman, Jorrit J Hornberg, Robert G Lowery.   

Abstract

ATP depletion and ADP formation are generic detection methods used for the identification of kinase and other ATP-utilizing enzyme inhibitors in high-throughput screening campaigns. However, the most widely used nucleotide detection approaches require high ATP consumption rates or involve the use of coupling enzymes, which can complicate the selection of lead compounds. As an alternative, we have developed the Transcreener (BellBrook Labs, Madison, WI) platform, which relies on the direct immunodetection of nucleotides. Here we describe the development of antibodies with >100-fold selectivity for ADP versus ATP, which enable robust detection of initial velocity rates (Z' > 0.7 at 10% substrate consumption) at ATP concentrations ranging from 0.1 microM to 1,000 microM in a competitive fluorescence polarization (FP) immunoassay. Competitive binding experiments indicate similar affinities for other nucleotide diphosphates, including 2' -deoxy ADP, GDP, and UDP. The antibody-tracer complex and the red-shifted, ratiometric FP signal are stable for at least 24 h at room temperature, providing suitable conditions for high-throughput screening. A method for calculating a kinase ATP Km with this FP immunoassay is also presented. The Transcreener ADP assay provides a simple, generic assay platform for inhibitor screening and selectivity profiling that can be used for any ADP-generating enzyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187009      PMCID: PMC2956686          DOI: 10.1089/adt.2008.175

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  31 in total

1.  Effect of pressure on antigen-antibody complexes: modulation by temperature and ionic strength.

Authors:  P Roy; C M Roth; M N Margolies; M L Yarmush
Journal:  Mol Immunol       Date:  1999-12       Impact factor: 4.407

Review 2.  Designing screens: how to make your hits a hit.

Authors:  W Patrick Walters; Mark Namchuk
Journal:  Nat Rev Drug Discov       Date:  2003-04       Impact factor: 84.694

3.  A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases.

Authors:  Elizabeth A Gaudet; Kuo-Sen Huang; Yan Zhang; Wei Huang; David Mark; J Richard Sportsman
Journal:  J Biomol Screen       Date:  2003-04

Review 4.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

5.  Identification of kinase inhibitors by an ATP depletion method.

Authors:  Pirthipal Singh; Benedict J Harden; Benjamin J Lillywhite; Peter M Broad
Journal:  Assay Drug Dev Technol       Date:  2004-04       Impact factor: 1.738

Review 6.  Transcreener: screening enzymes involved in covalent regulation.

Authors:  Robert G Lowery; Karen Kleman-Leyer
Journal:  Expert Opin Ther Targets       Date:  2006-02       Impact factor: 6.902

7.  BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice.

Authors:  James R Burke; Mark A Pattoli; Kurt R Gregor; Patrick J Brassil; John F MacMaster; Kim W McIntyre; Xiaoxia Yang; Violetta S Iotzova; Wendy Clarke; Joann Strnad; Yuping Qiu; F Christopher Zusi
Journal:  J Biol Chem       Date:  2002-10-25       Impact factor: 5.157

8.  Discovery and characterization of a substrate selective p38alpha inhibitor.

Authors:  Walter Davidson; Lee Frego; Gregory W Peet; Rachel R Kroe; Mark E Labadia; Susan M Lukas; Roger J Snow; Scott Jakes; Christine A Grygon; Christopher Pargellis; Brian G Werneburg
Journal:  Biochemistry       Date:  2004-09-21       Impact factor: 3.162

9.  Determination of 5-AMP in the presence of excess 3'(2')-AMP with the aid of antibodies raised against n6-carboxymethyl-5'-AMP conjugates. Use for the quantitation of pyridine nucleotides and of protein-bound ADP-ribose.

Authors:  R Bredehorst; M M Schlüter; H Hilz
Journal:  Biochim Biophys Acta       Date:  1981-01-29

10.  Preparation of cyclic nucleotide antisera with thyroglobulin-cyclic nucleotide conjugates.

Authors:  R A Richman; G S Kopf; P Hamet; R A Johnson
Journal:  J Cyclic Nucleotide Res       Date:  1980
View more
  15 in total

1.  Development and validation of a generic fluorescent methyltransferase activity assay based on the transcreener AMP/GMP assay.

Authors:  Tony A Klink; Matt Staeben; Kim Twesten; Andrew L Kopp; Meera Kumar; Rebecca Schall Dunn; Cori A Pinchard; Karen M Kleman-Leyer; Martin Klumpp; Robert G Lowery
Journal:  J Biomol Screen       Date:  2011-09-28

2.  Comparison of bioluminescent kinase assays using substrate depletion and product formation.

Authors:  Cordelle Tanega; Min Shen; Bryan T Mott; Craig J Thomas; Ryan MacArthur; James Inglese; Douglas S Auld
Journal:  Assay Drug Dev Technol       Date:  2009-12       Impact factor: 1.738

Review 3.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

4.  High-throughput screening for RecA inhibitors using a transcreener adenosine 5'-O-diphosphate assay.

Authors:  Eliza J R Peterson; William P Janzen; Dmitri Kireev; Scott F Singleton
Journal:  Assay Drug Dev Technol       Date:  2011-12-22       Impact factor: 1.738

5.  Development and validation of a transcreener assay for detection of AMP- and GMP-producing enzymes.

Authors:  Matt Staeben; Karen M Kleman-Leyer; Andrew L Kopp; Thane A Westermeyer; Robert G Lowery
Journal:  Assay Drug Dev Technol       Date:  2010-06       Impact factor: 1.738

6.  A fluorescent, reagentless biosensor for ADP based on tetramethylrhodamine-labeled ParM.

Authors:  Simone Kunzelmann; Martin R Webb
Journal:  ACS Chem Biol       Date:  2010-04-16       Impact factor: 5.100

7.  Two Galpha(i1) rate-modifying mutations act in concert to allow receptor-independent, steady-state measurements of RGS protein activity.

Authors:  Thomas Zielinski; Adam J Kimple; Stephanie Q Hutsell; Mark D Koeff; David P Siderovski; Robert G Lowery
Journal:  J Biomol Screen       Date:  2009-12

8.  Development of a Sensitive Assay for SERCA Activity Using FRET Detection of ADP.

Authors:  Meng Jing; Raffaello Verardi; Gianluigi Veglia; Michael T Bowser
Journal:  Anal Methods       Date:  2014-03-07       Impact factor: 2.896

9.  Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase.

Authors:  Mindy I Davis; Douglas S Auld; James Inglese
Journal:  Methods Mol Biol       Date:  2016

10.  A biosensor for fluorescent determination of ADP with high time resolution.

Authors:  Simone Kunzelmann; Martin R Webb
Journal:  J Biol Chem       Date:  2009-09-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.